Rhea: Digital Wellness Platform for Personalized Brain Rehabilitation

Rhea is a rehabilitation platform and startup grounded in science that delivers prescribed physical exercises to heal and care for the brain. Rhea’s simple directions, personalized exercise videos, and self-monitoring tools are drawn from well-established empirical evidence and clinical guidelines. 

Right now, Rhea's being used to improve quality of life and accelerate recovery for people suffering from concussion. Through novel algorithms that leverage self-reported information such as demographics, symptoms, and fitness level with wearable data (sleep patterns, daily activity, and heart rate), Rhea recommends the most effective mix of structured activities and exercises to facilitate the rehabilitation process following concussion.

OPPORTUNITY

Rhea is developing evidence-based Active Recovery programs that clinicians and individuals can use to support a range of brain health concerns – from concussion, to anxiety and depression and other long-term conditions.

Combined with in-person treatment, Rhea can transform how we treat brain injuries and mental health conditions. Rhea offers a digital solution at a fraction of the costs of traditional in-person therapy solutions, providing access to key rehabilitation strategies from a range of health professionals in one platform. The potential market opportunity of Rhea is not limited to concussion, and future versions of this digital platform will expand to other clinical populations including anxiety, depression, and post-traumatic stress, where the empirical evidence of structured exercise is well-documented.

STATUS

A company has been launched to commercialize the platform and technologies: Rhea

Rhea is currently conducting a large-scale usability study with its iOS platform across many different mechanisms including patients who have suffered from falls, work-related injuries, sports concussions and more.

Related Resources

VPRI Contact

Laurent Moreno

Innovations & Entrepreneurship Manager
Innovations & Partnerships Office (IPO)
(416) 946-0594